Where does Glenmark Pharmaceuticals S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Glenmark Pharmaceuticals S.A. ranks #6,535 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Glenmark Pharmaceuticals S.A. hold?

Glenmark Pharmaceuticals S.A. holds 51 US utility patents granted between 2015 and 2021, spanning 13 technology areas.

What is Glenmark Pharmaceuticals S.A.'s Innovation Score?

Glenmark Pharmaceuticals S.A. has an Innovation Score of 34.6 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Glenmark Pharmaceuticals S.A. focus on?

Glenmark Pharmaceuticals S.A.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 30 patents, ranking #655 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Glenmark Pharmaceuticals S.A.'s patent grant rate increasing or decreasing?

Glenmark Pharmaceuticals S.A.'s recent grant velocity is -94% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Glenmark Pharmaceuticals S.A.'s patents?

Glenmark Pharmaceuticals S.A.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Glenmark Pharmaceuticals S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Glenmark Pharmaceuticals S.A.

USPTO PatentsView assignee record - 51 granted patents across 13 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glenmark ranks #6,535 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 13 technology areas.

#6,535
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.6/100): 13.8
avg claims per patent: -94%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6535 · Foreign Corporation #6,535 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 51 grants
UPPER-Q #6,535/49,997
PHOTO-FINISH Fujimori Kogyo
CPC-FOCUS A61P · 13 areas
INNOV-THIN 34.6/100
CLAIMS-RICH 13.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -94% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fujimori Kogyo Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glenmark’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (39%) Velocity 0.0 pts (0%) Breadth 12.7 pts (37%) Claim depth 8.3 pts (24%)

Qualcomm Incorporated · highest

85
Comenity · near

35
Oclaro Japan · near

35
Alverix · near

35
Glenmark Pharmaceuti… · this assignee

35
Mission Therapeutics · near

35
3D Lighting… · lowest

7

What this shows Glenmark's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glenmark?

Each dot is one of Glenmark’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glenmark’s own 13.8 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Glenmark vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glenmark's grants concentrate

Glenmark Pharmaceuticals S.A. is a focused PatentsView assignee: 13 CPC subclasses with 58.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (15 grants) versus a trough of 1 in 2020. By volume, Glenmark sits between Fujimori Kogyo Co., Ltd. and Inergy Automotive Systems Research (Societe Anonyme).

Fujimori Kogyo

51
GDM S P A

51
Guangdong Bestek…

51
Guangzhou Tyrafos…

51
Glock Technology

51
Helsinn Healthcare

51
Howmet Aerospace

51
Inergy Automotive…

51
Glenmark Pharmace… ◀

51

What this shows Glenmark holds 51 patents at rank #6,537, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Glenmark

By rank, the assignees closest to #6,537 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Glenmark's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Glenmark, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Glenmark ranks #655 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Mission Therapeutics Limited 35 Alverix, Inc. 35 Oclaro Japan, Inc. 35 Comenity LLC 35

Similar claim depth

Nearest assignees by average claims per patent (13.8 here).

University OF Leicester 13.8 avg European Molecular Biology Laboratory 13.8 avg Aerin Medical Inc. 13.8 avg Lesaffre ET Compagnie 13.8 avg

Glenmark's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Glenmark Pharmaceuticals S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	13.7%
2016	10	19.6%
2017	15	29.4%
2018	9	17.6%
2019	7	13.7%
2020	1	2.0%
2021	2	3.9%

Which technologies does Glenmark Pharmaceuticals S.A. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 30

C07D - Heterocyclic Compounds 30

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

C07C - Acyclic OR Carbocyclic Compounds 12

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 6

C07K - Peptides 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

A23K - Fodder 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Glenmark Pharmaceuticals S.A.'s patent record in context - here's where to go next.

Glenmark Pharmaceuticals S.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 58.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,535 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Glenmark Pharmaceuticals S.A. against Fujimori Kogyo Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.